Latest News
Web Date: January 11, 2016

Thermo Fisher To Buy Affymetrix For $1.3 Billion

Deal expands instrument maker’s reach in genetic analysis for clinical and diagnostics markets
Department: Business
Keywords: acquisition, instrumentation, life sciences, consolidation

Thermo Fisher Scientific has reached a deal to buy gene-sequencing expert Affymetrix for $1.3 billion. The $14.00-per-share price is about 50% above Affymetrix’s share price after the stock market closed on Jan. 8.

Although not as large as Thermo Fisher’s $13.6 billion acquisition of Life Technologies in 2014, this latest acquisition further cements the firm’s role as a supplier of equipment and consumables to the . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society